52 results
Page 2 of 3
6-K
EX-1.2
r2rxsxmt86iln p8
8 May 20
Current Report
10:40am
424B5
ozs4 loj59n9w4hbj8
8 May 20
Prospectus supplement for primary offering
10:40am
6-K
EX-99.3
kzhn0llq
20 Apr 20
Report of Foreign Private Issuer
9:28am
F-1/A
EX-4.17
tal371veqjq8jao5pff
10 Mar 20
Registration statement (foreign) (amended)
8:13am
6-K
EX-99.2
f5d b8sm9shf51
8 Jan 20
Kitov Pharma Granted Additional 180-day Extension by Nasdaq to Comply with Bid Price Rule
7:46am
424B3
c7ghdg20k ha7
27 Dec 19
Prospectus supplement
4:30pm
F-3
imx ffvw0ceir89iwxm
2 Dec 19
Shelf registration (foreign)
4:46pm
6-K
EX-99.1
l14qgtxo3t q9c
11 Oct 19
Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch of ConsensiTMin the U.S
9:02am
6-K
EX-99.2
26mq1
8 Aug 19
Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update
4:32pm
20-F/A
EX-4.16
w39phu p92
3 Apr 19
Annual report (foreign) (amended)
7:38am
20-F/A
EX-4.17
7n0n8ut6ubmd q5
3 Apr 19
Annual report (foreign) (amended)
7:38am
6-K
EX-99.1
fg81fndbpa3tt
22 Mar 19
Report of Foreign Private Issuer
4:30pm
424B5
ywtww
18 Jan 19
Prospectus supplement for primary offering
12:03pm
6-K
EX-1.2
6p6mmm9 8x
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
EX-99.1
rrjpu31 2n5r7zpb
19 Dec 18
Report of Foreign Private Issuer
4:39pm
6-K
EX-1.2
jly1uz1xt8ki hi
5 Jun 18
Report of Foreign Private Issuer
4:25pm